Advertisement
Ear/Nose/Throat
Subscribe to Ear/Nose/Throat
View Sample

FREE Email Newsletter

Cell Phones Are Now Personal Diagnostic Tools That Can Monitor Fertility, Pathogens, AIDS, Drugs, and Allergens

December 15, 2010 4:31 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, HAARLEM, Netherlands, SHENZHEN, China and HUIZHOU, China, Dec. 15, 2010 /- GENTAG, Inc. and its partners have just demonstrated a new disposable wireless diagnostic test platform for consumer cell phones. The technology, based on immunoassays, can test for pregnancy,...

NKTR-102 Demonstrates Significant Efficacy as Single-Agent in Second- or Third-Line Treatment in Metastatic Breast Cancer Patients

December 12, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

SAN ANTONIO, and SAN FRANCISCO, Dec. 12, 2010 /- Nektar Therapeutics (Nasdaq: NKTR ) today announced positive results from a Phase 2 clinical study evaluating single-agent NKTR-102 in patients with metastatic breast cancer during the 33rd Annual CTRC-AACR San Antonio Breast Cancer...

The Biomarkers Consortium Announces Availability of Alzheimer's Disease Plasma Proteomics Data

December 7, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

BETHESDA, Md., Dec. 7, 2010 /- The Foundation for the National Institutes of Health's Biomarkers Consortium announced today that the results of a proteomics study performed utilizing plasma samples from the Alzheimer's Disease Neuroimaging Initiative (ADNI) are ready to be shared with...

Advertisement

Fuisz Pharma Releases Clinical Photos of Its Opioid Abuse Detection System

December 6, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

MIAMI, Dec. 6, 2010 /PRNewswire-USNewswire/ -- Fuisz Pharma today released photos of what the clinician will see in a standard nasal otoscopic exam in the case of a patient abusing an opioid, like Oxycontin® and others, through snorting. A food safe dye included in the tablet creates...

Unique Needs and Outcomes of Pregnant Women with Breast Cancer Identified

December 3, 2010 9:32 am | by AACR | News | Comments

SAN ANTONIO - Do not delay treatment of breast cancer just because a woman is pregnant, said lead researcher Sibylle Loibl, Dr. med, of the German Breast Group.

IBM and American Well Team to Enhance Security for Online Health Data

December 1, 2010 6:36 am | by IBM | News | Comments

IBM and American Well Inc. today announced an expanded partnership to further embed security into American Well's Online Care system in an effort to further safeguard patient information that is collected and exchanged as part of live Online Care consultations with healthcare providers....

The Truth About Diabetes and Visual Complications Unveiled

November 17, 2010 5:38 am | by Bio-Medicine.Org | News | Comments

PINELLAS PARK, Fla., Nov. 16, 2010 /- Diabetes is the number one cause of all recent agents of blindness in the United States among patients 24 to 74 years of age, according to Transitions Optical's Healthy Sight Institute.  Although this metabolic disorder is mainly diagnosed by a...

High tech genetic sequencing enables screening for hereditary hearing loss

November 16, 2010 11:35 am | by Baylor College of Medicine | News | Comments

Using a combination of special techniques to capture specific DNA sequences and high-throughput technology to sequence them, scientists from the Baylor College of Medicine Human Genome Sequencing Center and the University of Iowa developed a test to simultaneously screen more than 50...

Advertisement

Radiology Journal Publishes Data That PEM Scanners May Reduce Unnecessary Breast Biopsies and Offer an Alternative for Women Who Cannot Tolerate MRI

November 15, 2010 2:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 15, 2010 /- The Radiology journal released new data from an NIH-sponsored, multi-site study of hundreds of women with newly diagnosed breast cancer that shows Positron Emission Mammography (PEM) may reduce unnecessary breast biopsies.  The study found that PEM was...

The Acute Ischemic Stroke Drug Market Will Remain Relatively Flat, Increasing from $460 Million in 2009 to Approximately $610 Million in 2019

November 9, 2010 4:36 am | by Bio-Medicine.Org | News | Comments

BURLINGTON, Mass., Nov. 9, 2010 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the acute ischemic stroke (AIS) drug market will remain relatively flat, increasing from $460 million in 2009 to approximately...

Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib Development Program at 52nd American Society of Hematology Annual Meeting

November 9, 2010 4:35 am | by Bio-Medicine.Org | News | Comments

EMERYVILLE, Calif., Nov. 9, 2010 /- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced the presentation of several studies evaluating carfilzomib, a selective, next-generation proteasome inhibitor, at the American Society of Hematology (ASH) Annual Meeting, December 4-7, 2010, at...

Combating Childhood Cancer

November 7, 2010 10:31 pm | by San Diego Business Journal | News | Comments

Beth Anne Baber believes the intellectual capital, business acumen and philanthropic potential in San Diego provide the ideal environment to support the growth of a new institute that focuses on pediatric cancer research, diagnosis and treatment.

Netsmart Technologies Software Supports Shawnee Mental Health Center Integrated Mental Health and Primary Care Initiative

November 3, 2010 12:33 pm | by Bio-Medicine.Org | News | Comments

GREAT RIVER, N.Y., Nov. 3, 2010 /- Netsmart Technologies, Inc., a leading provider of software and services for health and human services organizations, announced that one if its mental health provider customers, Shawnee (Ohio) Mental Health Center, is achieving positive results from a...

Advertisement

Endologix Announces First Clinical Implant of Ventanaâ„¢ Stent Graft

November 2, 2010 6:36 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Nov. 2, 2010 /- Endologix, Inc. (Nasdaq: ELGX ), developer of minimally invasive treatments for aortic disorders, announced today the first clinical implant of the Company's Ventana™ fenestrated stent graft at Auckland City Hospital in Auckland, New Zealand....

Stater Bros. Super Rx Pharmacy Offers FREE Diabetic Medications

November 1, 2010 11:37 am | by Bio-Medicine.Org | News | Comments

SAN BERNARDINO, Calif., Nov. 1, 2010 /- According to the American Diabetes Association, total costs of diagnosed diabetes in the United States in 2007 were estimated at $174 billion.  Millions of Americans have been diagnosed with type II diabetes and many more are unaware that they...

Octapharma Clinical Trial Begins in the U.S. and Germany Treating Hemophilia A Patients with First Recombinant Factor VIII Derived from a Human Cell-Line

November 1, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

HOBOKEN, N.J., Nov. 1, 2010 /- Octapharma AG , one of the largest human protein products manufacturers in the world, and Octapharma USA today announced that patients diagnosed with severe hemophilia A have started treatment in a multi-center study that is researching the use of the first...

Accuray Announces Expanded Service Program

October 29, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Oct. 29 /- Accuray Incorporated, a global leader in the field of radiosurgery, announced today expansion of its Diamond service program to address the unique technical, business and operational needs of its customers. The Diamond service program has provided a means for...

IRIDEX Announces Third Quarter 2010 Conference Call and Release Date

October 28, 2010 11:33 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Oct. 28 /- IRIDEX Corporation (Nasdaq: IRIX ) today announced that it will release its third quarter 2010 financial results after the market closes on Thursday, November 4, 2010.  In conjunction with the release, the Company will host a conference call with the...

Telomere Length Affects Colorectal Cancer Risk

October 28, 2010 9:34 am | by AACR | News | Comments

PHILADELPHIA — For the first time, researchers have found a link between long telomeres and an increased risk for colorectal cancer, according to research presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held here Oct....

Country Music Star Teams up with JDRF to Inspire Kids With Diabetes and Raise Money for Research

October 28, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Oct. 28 /- In honor of November's Diabetes Awareness Month and World Diabetes Day 2010 (November 14), George Canyon , country music recording artist and Nashville Star finalist, will release his current Canadian hit single, "I Believe in Angels" in the U.S. and offer a special...

Free Diabetes Health Program Saturday, Oct. 30 at Jefferson State Community College

October 27, 2010 4:34 pm | by Bio-Medicine.Org | News | Comments

BIRMINGHAM, Ala., Oct. 27 /- The Institute for Health Protection (IHP), in partnership with Roche Diabetes Care, the makers of ACCU-CHEK® products and services, and Jefferson State Community College, will host a free community diabetes program at JSCC's Shelby-Hoover campus this...

Independent Clinical Results Demonstrate Outstanding Effectiveness of INVOcell Process

October 27, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

DENVER and BEVERLY, Mass., Oct. 27 /- INVO Bioscience, Inc. (OTC Bulletin Board: IVOB ), a medical device company focused on treatment options for patients diagnosed with infertility, announced today that Dr. Elkin Lucena of the Columbian Fertility and Sterility Center (CECOLFES LTDA) in...

Accuray Incorporated to Speak at Oppenheimer's 21st Annual Healthcare Conference

October 26, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Oct. 26 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the Oppenheimer Healthcare Conference in New York City on Wednesday, November 3, 2010 at 9:40 a.m. ET/6:40 a.m....

TearLab’s Goal Is to Make Sure There Isn’t a Dry Eye in the House

October 24, 2010 11:32 pm | by San Diego Business Journal | News | Comments

When James Owen first cast eyes on San Diego-based TearLab Corp.’s lab-on-a-chip approach to testing for eye disorders, he knew one major category of patients would be seeing improved results in their vision.

INVOcell Study Results to be Reported at the Annual Meeting of The American Society of Reproductive Medicine

October 22, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

DENVER and BEVERLY, Mass., Oct. 22 /- INVO Bioscience, Inc. (OTC Bulltin Board: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, today announced that Dr. Elkin Lucena of the Columbian Fertility and Sterility Center (CECOFLES LTDA) will...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading